Growth Metrics

Edwards Lifesciences (EW) Non Operating Income (2016 - 2025)

Edwards Lifesciences has reported Non Operating Income over the past 17 years, most recently at $3.2 million for Q4 2025.

  • Quarterly results put Non Operating Income at $3.2 million for Q4 2025, up 113.91% from a year ago — trailing twelve months through Dec 2025 was $34.0 million (up 21.0% YoY), and the annual figure for FY2025 was $7.2 million, down 89.55%.
  • Non Operating Income for Q4 2025 was $3.2 million at Edwards Lifesciences, up from $2.7 million in the prior quarter.
  • Over the last five years, Non Operating Income for EW hit a ceiling of $53.2 million in Q4 2023 and a floor of -$23.0 million in Q4 2024.
  • Median Non Operating Income over the past 5 years was $3.8 million (2022), compared with a mean of $7.2 million.
  • Biggest five-year swings in Non Operating Income: soared 1566.67% in 2021 and later plummeted 242.86% in 2022.
  • Edwards Lifesciences' Non Operating Income stood at $1.4 million in 2021, then soared by 314.29% to $5.8 million in 2022, then skyrocketed by 817.24% to $53.2 million in 2023, then crashed by 143.23% to -$23.0 million in 2024, then skyrocketed by 113.91% to $3.2 million in 2025.
  • The last three reported values for Non Operating Income were $3.2 million (Q4 2025), $2.7 million (Q3 2025), and -$11.0 million (Q2 2025) per Business Quant data.